(1S,2R)-2-(4-FLUOROPHENYL)CYCLOPROPANAMINE HCL, 95.0%, 250mg

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-b]pyridazine, 98%, 500mg

EDTA copper disodium salt x H2O, min. 99%, for synthesis, 500 g, plastic packaging.

Microliter syringe MICROLITER® series 7000 Point type 2, 0.5 µl, 7000.5 KH, 1 Piece

Fmoc-L-Glutamine, PEPTIPURE®, min. 98%, for biochemistry, 5 g, glass packaging

Nocodazole, 98%, 50mg

3-(4-iso-Propyl-phenoxymethyl)-4-methoxy-benzaldehyde, 1g

2-Fluoro-4-methylanisole, 95.0%, 5g

1-(4,5-Dihydro-1H-1,5-methanobenzo[d]azepin-3(2H)-yl)-2,2,2-trifluoroethanone, 95.0%, 5g

1-Chloro-9,10-bis(phenylethynyl)anthracene>96.0%(HPLC)(T)10g

5-Bromo-4-fluoro-2-methylbenzenesulfonyl chloride, 97.0%, 25g

Methoxymethyl Phenyl Sulfide>96.0%(GC)5g

2-Ethyl-2-methylsuccinic acid, 95%, 250mg